Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for KORU Medical Systems (KRMD) over the last 10 years, with Q3 2025 value amounting to $46.2 million.

  • KORU Medical Systems' Shares Outstanding (Diluted Average) rose 84.58% to $46.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.2 million, marking a year-over-year increase of 84.58%. This contributed to the annual value of $45.8 million for FY2024, which is 44.16% up from last year.
  • Latest data reveals that KORU Medical Systems reported Shares Outstanding (Diluted Average) of $46.2 million as of Q3 2025, which was up 84.58% from $46.2 million recorded in Q2 2025.
  • KORU Medical Systems' Shares Outstanding (Diluted Average)'s 5-year high stood at $46.2 million during Q3 2025, with a 5-year trough of $44.0 million in Q1 2021.
  • For the 5-year period, KORU Medical Systems' Shares Outstanding (Diluted Average) averaged around $45.3 million, with its median value being $45.6 million (2023).
  • Per our database at Business Quant, KORU Medical Systems' Shares Outstanding (Diluted Average) surged by 1024.69% in 2021 and then skyrocketed by 44.16% in 2024.
  • Quarter analysis of 5 years shows KORU Medical Systems' Shares Outstanding (Diluted Average) stood at $44.4 million in 2021, then grew by 1.39% to $45.0 million in 2022, then grew by 1.33% to $45.6 million in 2023, then rose by 0.44% to $45.8 million in 2024, then rose by 0.95% to $46.2 million in 2025.
  • Its last three reported values are $46.2 million in Q3 2025, $46.2 million for Q2 2025, and $46.0 million during Q1 2025.